|
English
|
正體中文
|
简体中文
|
总笔数 :2816822
|
|
造访人次 :
27602589
在线人数 :
525
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
"fehrenbacher l"的相关文件
显示项目 1-4 / 4 (共1页)
1
每页显示[10|25|50]项目
| 臺大學術典藏 |
2020-05-26T09:27:01Z |
ATLAS: Randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer
|
Johnson B.E;Kabbinavar F;Fehrenbacher L;Hainsworth J;Kasubhai S;Kressel B;Lin C.-Y;Marsland T;Patel T;Polikoff J;Rubin M;White L;Chih-Hsin Yang;Bowden C;Miller V.; Johnson B.E; Kabbinavar F; Fehrenbacher L; Hainsworth J; Kasubhai S; Kressel B; Lin C.-Y; Marsland T; Patel T; Polikoff J; Rubin M; White L; CHIH-HSIN YANG; Bowden C; Miller V. |
| 臺大學術典藏 |
2020-05-26T09:27:01Z |
ATLAS: Randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer
|
Johnson B.E;Kabbinavar F;Fehrenbacher L;Hainsworth J;Kasubhai S;Kressel B;Lin C.-Y;Marsland T;Patel T;Polikoff J;Rubin M;White L;Chih-Hsin Yang;Bowden C;Miller V.; Johnson B.E; Kabbinavar F; Fehrenbacher L; Hainsworth J; Kasubhai S; Kressel B; Lin C.-Y; Marsland T; Patel T; Polikoff J; Rubin M; White L; CHIH-HSIN YANG; Bowden C; Miller V. |
| 臺大學術典藏 |
2020-05-26T09:27:00Z |
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of Advanced Non-Small-Cell Lung Cancer (ATLAS)
|
Kabbinavar F;Fehrenbacher L;Hainsworth J;Kasubhai S;Kressel B;Marsland T;Patel T;Rubin M;White L;Chih-Hsin Yang;Klughammer B;Colburn D;Miller V;Johnson B.E.; Kabbinavar F; Fehrenbacher L; Hainsworth J; Kasubhai S; Kressel B; Marsland T; Patel T; Rubin M; White L; CHIH-HSIN YANG; Klughammer B; Colburn D; Miller V; Johnson B.E. |
| 臺大學術典藏 |
2020-05-26T09:27:00Z |
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of Advanced Non-Small-Cell Lung Cancer (ATLAS)
|
Kabbinavar F;Fehrenbacher L;Hainsworth J;Kasubhai S;Kressel B;Marsland T;Patel T;Rubin M;White L;Chih-Hsin Yang;Klughammer B;Colburn D;Miller V;Johnson B.E.; Kabbinavar F; Fehrenbacher L; Hainsworth J; Kasubhai S; Kressel B; Marsland T; Patel T; Rubin M; White L; CHIH-HSIN YANG; Klughammer B; Colburn D; Miller V; Johnson B.E. |
显示项目 1-4 / 4 (共1页)
1
每页显示[10|25|50]项目
|
